Abstract 11131: Discharge on Sacubitril/Valsartan vs. ACEi/ARB in Older Patients with HFrEF: A Decision Analysis Approach

Introduction: Based on the results of PARADIGM-HF and PIONEER-HF, angiotensin-receptor neprilysin inhibitors (ARNI) offer improved survival and lower readmission rates for HFrEF compared to angiote...